These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10933650)

  • 1. Attenuation of nephrotoxicity by a novel lipid nanosphere (NS-718) incorporating amphotericin B.
    Hossain MA; Maesaki S; Razzaque MS; Tomono K; Taguchi T; Kohno S
    J Antimicrob Chemother; 2000 Aug; 46(2):263-8. PubMed ID: 10933650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
    Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B
    Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against Aspergillus fumigatus.
    Otsubo T; Maesaki S; Hossain MA; Yamamoto Y; Tomono K; Tashiro T; Seki J; Tomii Y; Sonoke S; Kohno S
    Antimicrob Agents Chemother; 1999 Mar; 43(3):471-5. PubMed ID: 10049253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection.
    Kaur K; Kumar P; Kush P
    Biomed Pharmacother; 2020 Aug; 128():110297. PubMed ID: 32480227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models.
    Usman F; Nopparat J; Javed I; Srichana T
    Drug Deliv Transl Res; 2020 Feb; 10(1):59-69. PubMed ID: 31368043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity.
    Han K; Miah MA; Shanmugam S; Yong CS; Choi HG; Kim JA; Yoo BK
    Arch Pharm Res; 2007 Oct; 30(10):1344-9. PubMed ID: 18038914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotoxicity of amphotericin B is attenuated by solubilizing with lipid emulsion.
    Dórea EL; Yu L; De Castro I; Campos SB; Ori M; Vaccari EM; Lacaz Cda S; Seguro AC
    J Am Soc Nephrol; 1997 Sep; 8(9):1415-22. PubMed ID: 9294833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models.
    Brime B; Frutos P; Bringas P; Nieto A; Ballesteros MP; Frutos G
    J Antimicrob Chemother; 2003 Jul; 52(1):103-9. PubMed ID: 12805269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.
    Kang JY; Gao J; Shin DH; Alvarez C; Zhong W; Kwon GS
    Pharm Nanotechnol; 2016; 4(1):16-23. PubMed ID: 27774409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment.
    Nimtrakul P; Tiyaboonchai W; Lamlertthon S
    Curr Drug Deliv; 2019; 16(7):645-653. PubMed ID: 31362675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.
    Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2005 May; 55(5):727-34. PubMed ID: 15761070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of humoral mediators in, and influence of a liposomal formulation on, acute amphotericin B nephrotoxicity.
    Sabra R; Zeinoun N; Sharaf LH; Ghali R; Beshara G; Serhal H
    Pharmacol Toxicol; 2001 Apr; 88(4):168-75. PubMed ID: 11322173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B-induced nephrotoxicity: characterization of blood and urinary biochemistry and renal morphology in mice.
    Tonomura Y; Yamamoto E; Kondo C; Itoh A; Tsuchiya N; Uehara T; Baba T
    Hum Exp Toxicol; 2009 May; 28(5):293-300. PubMed ID: 19661263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
    Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
    Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone.
    Italia JL; Yahya MM; Singh D; Ravi Kumar MN
    Pharm Res; 2009 Jun; 26(6):1324-31. PubMed ID: 19214716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Must we really fear toxicity of conventional amphotericin B in oncological patients?
    Mayer J; Doubek M; Vorlìcek J
    Support Care Cancer; 1999 Jan; 7(1):51-5. PubMed ID: 9926976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fasting on temporal variation in the nephrotoxicity of amphotericin B in rats.
    LeBrun M; Grenier L; Bergeron MG; Thibault L; Labrecque G; Beauchamp D
    Antimicrob Agents Chemother; 1999 Mar; 43(3):520-4. PubMed ID: 10049261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells.
    Wegner B; Baer P; Gauer S; Oremek G; Hauser IA; Geiger H
    Nephrol Dial Transplant; 2005 Oct; 20(10):2071-9. PubMed ID: 15998654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS).
    Fukui H; Koike T; Saheki A; Sonoke S; Tomii Y; Seki J
    Int J Pharm; 2003 Sep; 263(1-2):51-60. PubMed ID: 12954180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.